We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$150B
AUM Growth
+$12.9B
Cap. Flow
+$4.72B
Cap. Flow %
3.14%
Top 10 Hldgs %
14.8%
Holding
3,187
New
75
Increased
2,456
Reduced
443
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$175M
2
INTC icon
Intel
INTC
+$154M
3
AMZN icon
Amazon
AMZN
+$115M
4
IBM icon
IBM
IBM
+$97.2M
5
PLD icon
Prologis
PLD
+$92.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$156M
2
GGP
GGP Inc.
GGP
+$135M
3
TSM icon
TSMC
TSM
+$111M
4
DCT
DCT Industrial Trust Inc.
DCT
+$81.8M
5
XL
XL Group Ltd.
XL
+$59.6M

Sector Composition

Rank Sector Weight
1 Technology 16.59%
2 Financials 14.04%
3 Healthcare 13.2%
4 Industrials 10.93%
5 Consumer Discretionary 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXFD
2701
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$775K ﹤0.01%
47,700
MRNS
2702
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$774K ﹤0.01%
19,350
+2,400
+14% +$68.3K
LBY
2703
DELISTED
Libbey, Inc.
LBY
$767K ﹤0.01%
87,627
+20,405
+30% +$187K
BLBD icon
2704
Blue Bird Corp
BLBD
$2.1B
$766K ﹤0.01%
31,260
-22,035
-41% -$506K
IPI icon
2705
Intrepid Potash
IPI
$496M
$764K ﹤0.01%
21,270
CDMO
2706
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$752K ﹤0.01%
109,500
+15,000
+16% +$88.9K
CYRX icon
2707
CryoPort
CYRX
$757M
$746K ﹤0.01%
58,230
+3,530
+6% +$50.4K
SFS
2708
DELISTED
Smart & Final Stores, Inc.
SFS
$744K ﹤0.01%
130,491
-64,963
-33% -$409K
MLNT
2709
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$740K ﹤0.01%
37,442
+2,371
+7% +$59.9K
MXWL
2710
DELISTED
Maxwell Technologies Inc
MXWL
$739K ﹤0.01%
211,581
+25,053
+13% +$101K
GEOS icon
2711
Geospace Technologies
GEOS
$69.2M
$733K ﹤0.01%
53,434
+1,067
+2% +$14.7K
MEET
2712
DELISTED
The Meet Group, Inc. Common Stock
MEET
$733K ﹤0.01%
148,074
+6,030
+4% +$27K
HCI icon
2713
HCI Group
HCI
$2.29B
$732K ﹤0.01%
16,726
JCAP
2714
DELISTED
Jernigan Capital, Inc.
JCAP
$732K ﹤0.01%
37,897
+9,660
+34% +$184K
UTMD icon
2715
Utah Medical Products
UTMD
$229M
$731K ﹤0.01%
7,751
+286
+4% +$27.3K
TPB icon
2716
Turning Point Brands
TPB
$1.77B
$730K ﹤0.01%
17,604
HBCP icon
2717
Home Bancorp
HBCP
$564M
$724K ﹤0.01%
16,646
NC icon
2718
NACCO Industries
NC
$306M
$724K ﹤0.01%
22,104
-3,347
-13% -$114K
AVEO
2719
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$723K ﹤0.01%
21,813
GSHD icon
2720
Goosehead Insurance
GSHD
$2.32B
$715K ﹤0.01%
21,100
+2,800
+15% +$81.2K
CATC
2721
DELISTED
CAMBRIDGE BANCORP
CATC
$713K ﹤0.01%
7,917
CCRN
2722
DELISTED
Cross Country Healthcare
CCRN
$710K ﹤0.01%
81,215
+6,000
+8% +$61.3K
NKSH icon
2723
National Bankshares
NKSH
$269M
$709K ﹤0.01%
15,588
RCUS icon
2724
Arcus Biosciences
RCUS
$3.66B
$708K ﹤0.01%
50,747
+10,706
+27% +$137K
FRBK
2725
DELISTED
Republic First Bancorp Inc
FRBK
$705K ﹤0.01%
98,584

Similar funds

Charles Schwab's Q3 2018 Portfolio in Review

As of Q3 2018, Charles Schwab held 3,187 positions worth $150B, up 9.4% from $137B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Charles Schwab deployed $4.72B of net new capital in Q3 2018, opening 75 new positions and adding to 2,456 existing holdings. Its largest new stake was KKR & Co: 895,988 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $156M trimmed.

  • Charles Schwab's largest Q3 2018 buy was KKR & Co: 895,988 shares worth $24.4M.
  • Charles Schwab added most to Microsoft in Q3 2018, an estimated $175M increase.
  • Charles Schwab's biggest Q3 2018 reduction was Apple, cutting an estimated $156M.
  • Charles Schwab fully exited GGP Inc. in Q3 2018, selling an estimated $135M.
  • Charles Schwab's ten largest holdings make up 15% of its $150B portfolio in Q3 2018.
  • Charles Schwab opened 75 new positions and closed 56 in Q3 2018.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $150B.

Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.